PRMT1 and breast cancer: Similarly, we have previously characterized an alternatively spliced isoform (v2) of PRMT1 that is specifically over-represented in breast cancer and shown that it promotes evasion from apoptosis and metastatic potential in breast cancer cells, at least in part through regulation of β-Catenin expression10, 11.